Target intelligence / Profile preview

Bacterial lipopolysaccharide O-antigen (O-antigen)

Target
O-antigen
Molecular classification
Polysaccharide, Glycan, Lipopolysaccharide component
01

Overview

Bacterial lipopolysaccharide (LPS) O-antigens are the highly variable, outermost polysaccharide components of the LPS molecule found in the outer membrane of Gram-negative bacteria. They consist of repeating oligosaccharide units that extend from the bacterial surface, serving as a critical interface between the pathogen and the host environment. O-antigens play a vital role in bacterial pathogenesis by providing a physical barrier against host immune defenses, such as complement-mediated lysis and phagocytosis, and by facilitating motility and biofilm formation. Due to their high immunogenicity and surface exposure, O-antigens are primary targets for the development of serotype-specific vaccines and monoclonal antibodies. However, their extreme structural diversity across different bacterial strains and species presents a significant challenge for broad-spectrum therapeutic development, often necessitating multivalent or strain-specific approaches.

Other names
O-polysaccharideO-side chainO-specific polysaccharideO-antigenic determinantOPS
02

Mechanism of action

Drugs targeting O-antigens primarily work through neutralization of bacterial attachment, opsonization to enhance phagocytosis, and activation of the classical complement pathway to mediate bacterial killing. Vaccines induce the production of serotype-specific antibodies that bind to the O-antigen, preventing colonization and promoting immune clearance of the pathogen.

03

Biological functions

Structural integrityImmune evasionComplement resistancePhagocytosis inhibitionBiofilm formationCell motilitySerological specificity
04

Disease associations

InfectionSepsisPneumoniaDysenteryCholeraCystic fibrosis
05

Safety considerations

Serotype switching and escape mutantsNarrow spectrum of activity due to high variabilityRequirement for multivalent formulationsPotential for cross-reactivity with host glycans
06

Interacting drugs

Vaxchora

8 more in the full profile.

07

Biomarkers

O-antigen serotypingAnti-O-antigen antibody titersLPS serum levels

Beyond the preview

Go deeper on Bacterial lipopolysaccharide O-antigen (O-antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial lipopolysaccharide O-antigen (O-antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call